Application 761029
- Type
- BLA
- Sponsor
- BIOGEN
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 761029 | Zinbryta | daclizumab | 351(a) | Disc | 2026-06-01 |
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ZINBRYTA | DACLIZUMAB | INJECTABLE;INJECTION | 150MG/ML | Yes | No |
NDC Listings For This Application#
NDC listings for this application page 1 of 1 ยท 2 matching rows.
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0074-0033 | Zinbryta | Daclizumab | Abbvie | BLA | Current |
| 0074-0034 | Zinbryta | Daclizumab | Abbvie | BLA | Current |